US Map / Maine
State ME

Clinical Trials in Maine

Maine is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Maine and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 30 actively recruiting studies with Maine sites out of 30 registered in total. The busiest research areas in Maine are Non-small Cell Lung Cancer, Acute Myeloid Leukemia, Lymphoma, Non-Hodgkin. Leading sponsors running trials in the state include National Cancer Institute (NCI), NRG Oncology, SWOG Cancer Research Network. By stage, Maine trials break down as Phase 1 (1), Phase 2 (9), Phase 3 (17), Phase 4 (3).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
30
Recruiting Now
30
← Back to US Map
Top Conditions in Maine
Non-small Cell Lung Cancer (2)Acute Myeloid Leukemia (2)Lymphoma, Non-Hodgkin (1)Multiple Myeloma (1)Advanced Solid Tumors (1)Diabetic Retinopathy (1)Low Grade Astrocytoma (1)Low Grade Glioma (1)Metastatic Low Grade Astrocytoma (1)Metastatic Low Grade Glioma (1)WHO Grade 1 Glioma (1)WHO Grade 2 Glioma (1)

Frequently Asked Questions — Clinical Trials in Maine

How many clinical trials are currently recruiting in Maine?
ClinicalMetric currently tracks 30 actively recruiting clinical trials with at least one location in Maine. The total number of registered studies—including active but not currently enrolling trials—is 30. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Maine?
Maine hosts clinical trials across a broad range of medical conditions, including Non-small Cell Lung Cancer, Acute Myeloid Leukemia, Lymphoma, Non-Hodgkin, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Maine serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Maine?
To join a clinical trial in Maine, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Maine maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Maine

NCT02693535 Phase 2
Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That...
Condition
Lymphoma, Non-Hodgkin
Enrollment
4,200 pts
Location
United States, Puerto Rico
Sponsor
American Society of Clinical O
View Trial →
NCT07592273 Phase 2, Phase 3
Recruiting
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Particip...
Condition
Diabetic Retinopathy
Enrollment
576 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
View Trial →
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05076175 Phase 2, Phase 3
Recruiting
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Mod...
Condition
Colitis, Ulcerative
Enrollment
120 pts
Location
United States, Australia, Belgium
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06692738 Phase 3
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for...
Condition
Non-small Cell Lung Cancer
Enrollment
1,160 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT05624996 Phase 3
Recruiting
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for...
Condition
Locally Advanced Lung Non-Small Cell Carcinoma
Enrollment
474 pts
Location
United States, Canada
Sponsor
NRG Oncology
View Trial →
NCT06581328 Phase 4
Recruiting
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in t...
Condition
Ulcerative Colitis
Enrollment
400 pts
Location
United States
Sponsor
Takeda
View Trial →
NCT07582432 Phase 3
Recruiting
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex i...
Condition
Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
Enrollment
49 pts
Location
United States
Sponsor
Grifols Biologicals, LLC
View Trial →
NCT03180268 Phase 3
Recruiting
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade...
Condition
Grade 2 Meningioma
Enrollment
163 pts
Location
United States, Canada, India
Sponsor
NRG Oncology
View Trial →
NCT06616584 Phase 2, Phase 3
Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Adva...
Condition
Recurrent Lung Non-Small Cell Carcinoma
Enrollment
378 pts
Location
United States
Sponsor
SWOG Cancer Research Network
View Trial →
NCT04398628 N/A
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Condition
Hematologic Disorder
Enrollment
3,000 pts
Location
United States
Sponsor
American Thrombosis and Hemost
View Trial →
NCT07018869 Phase 3
Recruiting
Evaluating Whether an Educational Website Called Current Together After Cancer (...
Condition
Colorectal Cancer Stage II
Enrollment
1,057 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
View Trial →
NCT06317649 Phase 2
Recruiting
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute M...
Condition
Acute Myeloid Leukemia
Enrollment
147 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06494904 Phase 3
Recruiting
Standard Versus High Dose ED-Initiated Buprenorphine Induction
Condition
Opioid Use Disorder
Enrollment
360 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT07544680 N/A
Recruiting
Endometrial Cancer Vaginal Fluid Specimen Collection Study
Condition
Abnormal Uterine Bleeding (AUB)
Enrollment
4,200 pts
Location
United States
Sponsor
Exact Sciences Corporation
View Trial →
NCT06223269 Phase 3
Recruiting
Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wound...
Condition
Burns Degree Third
Enrollment
50 pts
Location
United States
Sponsor
XenoTherapeutics, Inc.
View Trial →
NCT04682483 N/A
Recruiting
Cardiogenic Shock Working Group Registry
Condition
Cardiogenic Shock
Enrollment
5,000 pts
Location
United States
Sponsor
Tufts Medical Center
View Trial →
NCT06958328 Phase 3
Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Condition
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma
Enrollment
356 pts
Location
United States, Canada
Sponsor
NRG Oncology
View Trial →
NCT00358943 N/A
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Preg...
Condition
Gaucher Disease
Enrollment
12,000 pts
Location
United States, Argentina, Australia
Sponsor
Genzyme, a Sanofi Company
View Trial →
NCT06966700 Phase 3
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Br...
Condition
Breast Neoplasms
Enrollment
2,400 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT05099003 Phase 1, Phase 2
Recruiting
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diag...
Condition
Malignant Glioma
Enrollment
132 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
View Trial →
NCT06116682 Phase 2
Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Co...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
88 pts
Location
United States
Sponsor
SWOG Cancer Research Network
View Trial →
NCT05059444 N/A
Recruiting
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Condition
Bladder Carcinoma
Enrollment
2,020 pts
Location
United States, France, Germany
Sponsor
Guardant Health, Inc.
View Trial →
NCT07496567 Phase 2, Phase 3
Recruiting
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-...
Condition
Macular Degeneration
Enrollment
960 pts
Location
United States, Brazil, Colombia
Sponsor
EyeBiotech Ltd.
View Trial →
Page 1 of 2 — 30 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology